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guide-wire was passed to original lumen. Next, another guide-wire was passed into
calcified atheroma with intravascular ultrasound guided and dilated the calcified lumen
by balloon angioplasty or rotational atherectomy. Thus, calcified lumen was connected
with original one, the optimal balloon or stent expansion could achieve.
Results: Twenty-eight PAD patients (71.2 ± 10.9 years, 68.9% male) with eccentric
calcification were tried ARCADIA procedure. Fourteen patients had advanced renal
failure on hemodialysis. The lesion was located in the common iliac artery in 8 patients,
common and superficial femoral artery in 20 patients. We failed to pass the wire into
calcification in 4 cases (success rate was 85.7%). Mean follow-up period was 163.5 ±
153.6 days. Ankle brachial index was significantly higher when following up (pre: 0.49
± 0.31 vs. follow-up: 0.74 ± 0.18, p<0.01, 95%CI: 0.13-0.36). Target lesion
revascularization occurred one case (rate was 3.5%). There were no procedural
complication and no in-hospital major adverse cardiovascular events.
Concept of ARCADIA Technique
Conclusion: ARCADIA technique is one of the options to achieve optimal balloon or
stent expansion by dilatation from inside of calcification. It could be effective to PAD
with severe calcification.
TCT-590
Endovascular Peripheral and Visceral Aneurysms Repair with Cardiatis
Multilayer Flow Modulator: Results at 6 and 12 Months Follow Up
Maria Antonella Ruffino, Pierluigi Muratore, Claudio Rabbia
Vascular and Interventional Radiology, San Giovanni Battista Hospital, Torino, Italy
Background: To show efficacy of Cardiatis Multilayer Flow Modulator (CMFM) in
the treatment of peripheral and visceral aneurysms with/without collateral branches
arising from the sac or proximal/distal neck.
Methods: Between june 2009 and june 2010, 54 patients with peripheral (35) and
visceral (19) aneurysms were treated with CMFM in 22 italian clinical centers (16
Interventional Radiology, 3 Vascular Surgery, and 3 Cardiovascular Unit). 40/54
aneurysms had collateral branches arising from the sac or the necks of the lesion. Early
(30 days), midterm (6 months) and late term (12 months) results were analyzed in
terms of technical and clinical success (aneurysm thrombosis, stent and branches
patency); we assessed also the shrinkage/diameter reduction of the sac at 6 and 12
months. All data were recorded in the Italian Registry of Cardiatis Procedures
supported by the Italian Society of Vascular and Interventional Radiology.
Results: Technical success was achieved in all the cases. Clinical success was
evaluated with CT-angiography. We report the data we collected from all the patients
with at least one month FU (49 patients). The 30-days, 6-months and 12-months
clinical success rates (aneurysm thrombosis) were 91,8% (45/49), 95,7% (45/47), and
92,3% (24/26) rispectively, with a 100% rates of side branches patency and stent
patency at the latest FU. While shrinkage at 6 months FU was observed in 70% of
patients, at 12 months FU it was present in 80,8% of cases.
Conclusion: Our experience shows that CMFM appears to be an affective tool in
endovascular exclusion of peripheral and visceral aneurysms with collateral branches,
allowing sac thrombosis and collateral vessels patency with significant
shrinkage/diameter reduction of the sac, allowing a broader group of patients to be
treated with endovascular repair.
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A New Concept of Stent:the Multilayer Stent.First Human Study in
TAAA&AAA
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Background: Thoraco Abdominal Aortic Aneurysms(TAA)&Abdominal Aortic
Aneurysms (AAA)are traditionally treated surgically but more and more by
interventional procedures(endografts or fenestrated grafts) with a high technical success
rate,but some problems are not solved like protection of aneurysm
rupture,endoleaks,neurological compl. like paraplegia.We developed a new concept of
stent,the Multilayer stent(MS) to treat these aneurysms and try to avoid some major
complications.
Methods: This MS is a 3D braided tube made of several interconnected layers without
any covering.Our earliest in vitro tests(theorical simulation,computerized Fluid
dynamics,Molecular Modelization)&in vivo tests demonstrate that this MS reduces
the velocity in the aneurismal sac up to90% by modifying the hemodynamic
conditions.A saccular aneurysm without collateral branch will thrombose quickly.If a
collateral branch is present the flow is directed towards this branch leading to shrinkage
of the aneurysm.In fusiform aneurysms the flow is laminated,the vortices
eliminated,reducing the risk of rupture.Animal experiments show excellent
results.Moreover,as demonstrated in animal &human studies this MS preserves the
collateral branches allowing the possibility to cover any artery without compromising
the flow(renal,digestive arteries,supra aortic vessels)
Results: 6 TAA,4 AAA(3 extended to both iliac arteries)in 10 compassionate
cases(˛:9,ˇ:1, mean age 61,4y)were treated with the MS,23 stents(Ø12 to 40 mm,L:8
to 15cm) were implanted by femoral approach. Technical success 100%.No
periprocedural complications.6 to 18 months follow up will be presented.All these
aneurysms were thrombosed with Øreduction in some cases.We will discuss the time
needed to achieve their exclusion. It seems related to the nb and size of the branches
within the aneurysms.All the side branches covered by the MS remained patent
Conclusion: The MS is a new technique which seems promising to treat AAA
&TAAA. It allows to cover any artery without compromising the flow. Larger study is
ongoing.
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Antibiotic-Bonded Aortic Graft for Prevention of Vascular Graft Infection
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Background: Perioperative infection of an aortic graft is one of the most devastating
complications in vascular surgery (mortality is 10-30%). The amputation rate is
generally >25%, depending on anatomic location, graft material, and virulence of the
bacteria. In vitro studies suggest that an antibiotic-impregnated graft could help to
prevent post-graft infection. Generally, staphylococci cause up to 40% of vascular graft
infections. In a pilot study conducted in an animal model, we tested a locally developed
technique of bonding aortic grafts with 2 different antibiotics to evaluate its synergistic
preventative effect on direct perioperative bacterial contamination.
Methods: Vascular Dacron grafts, 6 mm in diameter, were surgically implanted in the
infrarenal portion of the abdominal aorta of 6 Sinclair Miniature swine. Two pigs
received a graft that had been bonded with 60 mg/mL solutions of rifampin and
minocycline; the other 4 pigs received unbonded grafts. Before implantation, the 2
bonded grafts and 2 of the 4 unbonded grafts were immersed in 2 mL of a bacterial
solution containing 1 to 2×107 colony-forming units (CFU)/mL of S. aureus (ATCC
29213) for 15 minutes. Two weeks after graft implantation, the pigs were sacrificed.
Results: Whereas specimens of the 2 S. aureus–treated unbonded grafts had high
bacterial counts (6.25×106 and 1.38×107 CFU/graft), specimens of the 2 S. aureus–
treated bonded grafts showed no bacterial growth. Bacterial growth in the 2 control
pigs’ grafts (1.8×103 and 7.27×103 CFU/graft) reflected direct accidental perioperative
bacterial contamination; the organisms isolated were not S. aureus (S. cohnii spp
urealyticus and S. chromogenes). The histopathologic and clinical data confirmed the
microbiological findings. Only pigs that received unbonded grafts showed
histopathologic evidence of perigraft abscess.
Conclusion: Our results suggest that bonding aortic grafts with 2 antibiotics is a
promising method of reducing direct perioperative bacterial contamination. Further
studies are needed to explore the ability of this novel graft to combat one of the most
feared complications in vascular surgery.
TCT-593
Relationship between novel angiographic endpoint of endovascular therapy and
clinical result of patients with critical limb ischemia
Makoto Utsunomiya, Masato Nakamura, Kaoru Sugi
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center,
Tokyo, Japan
Background: The optimal angiographic endpoint of endovascular therapy (EVT)
remains unclear. The aim of this study was to assess the relationship between the
appearance of wound blush as an angiographic endpoint and the limb salvage rate in
patients with CLI.
Methods: Wound blush was defined as contrast opacification of the vessels around
the wound in digital subtraction angiograms obtained immediately after the EVT
through the catheter introduced into the popliteal artery. We analyzed the data of 77
consecutive patients (93 limbs) with ischemic ulcerations classified as Rutherford
category 5 or 6, who underwent EVT alone. Patients were divided into two groups
depending on whether or not wound blush was obtained in the angiogram obtained
immediately after the procedure, and the ‘freedom from amputation’ rate was compared
between the two groups.
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significantly higher in the wound blush-positive group than in the wound blush-
negative group, and remained so for at least 3 years after the EVT (96.4% vs. 56.8%,
P<0.001).
Conclusion: Wound blush as an angiographic endpoint in EVT may be a novel
predictor of limb salvage in patients with CLI.
TCT-594
Clinical Outcomes Using the Viabahn Stent Graft in Complex Femoropopliteal
Lesions
Peter Mohr, Curtiss Stinis
Scripps Clinic, La Jolla, CA
Background: The optimal endovascular treatment for complex femoropopliteal (FP)
disease is unknown. Percutaneous transluminal angioplasty (PTA) carries a high rate
of restenosis while nitinol stent implantation can result in fractures. The Viabahn stent
graft (Gore Medical; Flagstaff, AZ) was developed to reduce restenosis and increase
overall flexibility. The purpose of this study was to evaluate the efficacy of the Viabahn
stent graft in complex FP disease.
Methods: We evaluated 57 limbs in 48 patients receiving Viabahn stent grafts. Patient
demographics, comorbidites, and procedural details were collected. Outcomes included
primary patency, assisted primary patency, secondary patency, and pre- and
postprocedural ankle brachial index and Rutherford classification.
Results: The study group consisted primarily of TASC II C (n=27;47%) and D
(n=24;42%) lesions (mean age 74.5; male sex=68%). Indications for revascularization
were lifestyle limiting claudication (70.2%), critical limb ischemia (28.1%), and
popliteal aneurysm exclusion (8.8%). Twenty-six patients (46%) had undergone
previous PTA, and 8 patients (14%) had undergone previous peripheral bypass. The
average graft length was 25.4 cm, with an average of 2.1 grafts implanted. There were
no periprocedural complications. Follow-up was available for 53 limbs (93%) with a
mean follow-up of 8.5 months (range 1-22). Average ABI improved from 0.59 to 0.96.
Eight limbs (15.1%) experienced restenosis and 5 limbs (9.4%) had an occlusion. The
primary patency rate for the mean follow-up time was 75.5%. Assisted primary patency
was 90.6% (all restenotic limbs successfully revascularized) and secondary patency
was 96.2% (3 of 5 occlusions with restored patency). At follow-up, 42 patients (80.8%)
were symptom free, 8 patients (15.4%) had Rutherford Class 2-3 symptoms, and 1
patient (1.9%) had critical limb ischemia.
Conclusion: Viabahn stent grafting is a safe and effective option for patients with
complex FP lesions. Patency rates are favorable despite the complexity of disease.
Restenosis and occlusion, while uncommon, can occur which mandates close follow-
up.
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One year clinical outcomes of MISAGO2 the large multicentre study with
Misago the new self-expanding nitinol peripheral stent - final results
Karl-Ludwig Schulte1, Ivan Kralj2, Frank Vermassen3, Marc Sapoval4, Ralf
Langhoff1, Stefan Müller Hülsbeck5, Jan H Peregrin6, Michael Åkesson7, Thomas
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Background: The main purpose of this study was to assess on the large patient
population the performance and clinical outcome of Misago SX nitinol stent in the
treatment of superficial femoral (SF) or popliteal arteries
Methods: MISAGO 2 registry enrolled 744 patients undergoing percutaneous
intervention of stenotic or occluded lesions in SF or popliteal arteries in 76 centres
across Europe. In total 754 lesions were treated with 916 stents. All clinical events are
independently adjudicated. The primary endpoint was absence of clinically driven
target lesion revascularization at 6 and 12 months.
Results: Patients (67% male) were 69±10 years old, 68% had hypertension, 60% were
smokers and 35% diabetes. Average lesion length was 64±38 mm, 38% lesions were
totally occluded and 64% massively or moderately calcified. Technical and procedural
success rates were 99%. 12-Month follow-up done on more than 90% of the subjects
treated at baseline (655) showed freedom from target lesion revascularization of 89.6%
and primary patency rate of 87.6%. Total number of subjects with any adverse event
(any death, amputation, revascularization, vascular, bleeding and cerebrovascular
event) was 14.8%. Ankle brachial index increased for more than 0.1 in 76% of the
subjects, and Rutherford index improved in 87% of the subjects. There was no
clinically relevant (grade 3&4 out of 4)stent fracture reported in the study. Overall
fracture rate was 3.1.
Conclusion: Results of the large multicentre MISAGO 2 registry that evaluated
Misago RX system in SFA and popliteal arteries showed excellent TLR and primary
patency rate at one year. Low fracture rate observed was not related with any of TLR
occurred.
TCT-596
Factors Related to the Failure of Limb Salvage Following Endovascular
Therapy in Patients with Critical Limb Ischemia
Shin Okamoto, Osamu Iida, Masaaki Uematsu
Kansai Rosai Hospital, Amagasaki city, Japan
Background: Although endovascular therapy (EVT) has been shown efficacious in
patients with critical limb ischemia (CLI), EVT is not always successful in limb
salvage. We sought to investigate the factors related to the failure of limb salvage
following EVT.
Methods: Consecutive 358 legs from 307 CLI patients (Rutherford 4 to 6) who
underwent EVT were enrolled between April, 2003 and April, 2009. Primary endpoint
comprised amputation or bypass surgery. Patients were followed for 20 +/- 16 months.
Logistic regression analysis was performed to explore the independent determinants
of the prognosis of the legs.
Results: Initial success rate was 86%. Bypass surgery or amputation was done in 78
limbs. Age, ankle brachial index, hypertension, Rutherford class and distal blood flow
below the ankle were chosen as independent variables by single regression analysis.
Among these, distal blood flow was chosen as the strongest independent predictor
associated with the prognosis of the legs by multivariate analysis (Table).
Conclusion: Poor flow below the ankle was the strongest factor related to the failure
of limb salvage following EVT.
TCT-597
Utilization of Imaging Modalities Prior to Amputation Among Patients With
Peripheral Arterial Disease or Diabetes — A Nationwide Study
Sumeet Subherwal1, Emil L Fosbol1, 3, Lars Kober2, William S Jones1, Gunnar H
Gislason3, Christian Torp-Pederersen3, Manesh R Patel1
1Duke Clinical Research Institute, Duke University, Durham, NC; 2The Heart
Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; 33.
Department of Cardiology, Copenhagen University Hospital Gentofte,, Copenhagen,
Denmark
Background: Non-traumatic lower extremity amputation is associated with significant
morbidity and mortality. With the emergence of newer improved therapies for
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